Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas W Jobling

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
The Journal of the British Menopause Society|April 9, 2005
Advances in the treatment of endometrial cancerMartin K Oehler, Alison Fung, Thomas W Jobling
Journal of Gynecologic Oncology|September 26, 2015
Surgical staging of para-aortic LN in patients with locally advanced cervix cancer and no evidence of metastases in preoperative PET/CT imagingMing Yin Lin, Thomas W Jobling, Kailash Narayan
Cell and Tissue Research|June 11, 2005
Endometrial cancerAndrew J Ryan, Beatrice Susil, Thomas W Jobling, et al.
Cancers|August 25, 2019
Keratin-14 (KRT14) Positive Leader Cells Mediate Mesothelial Clearance and Invasion by Ovarian Cancer CellsMaree Bilandzic, Adam Rainczuk, Emma Green, et al.
Diagnostics (Basel, Switzerland)|July 2, 2021
Active Ratio Test (ART) as a Novel Diagnostic for Ovarian CancerSung-Woog Kang, Adam Rainczuk, Martin K Oehler, et al.
Diagnostics (Basel, Switzerland)|January 7, 2021
Diagnostic Value of Plasma Annexin A2 in Early-Stage High-Grade Serous Ovarian CancerNoor A Lokman, Carmela Ricciardelli, Andrew N Stephens, et al.
Acta Obstetricia Et Gynecologica Scandinavica|January 15, 2013
Surgical management of placenta accreta: a 10-year experienceS E Grace Tan, Thomas W Jobling, Euan M Wallace, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 2, 2021
Chemoresistance is mediated by ovarian cancer leader cells in vitroNazanin Karimnia, Amy L Wilson, Emma Green, et al.
Cancers|August 27, 2021
Mapping Epitopes Recognised by Autoantibodies Shows Potential for the Diagnosis of High-Grade Serous Ovarian Cancer and Monitoring Response to Therapy for This MalignancyRhiane Moody, Kirsty Wilson, Nirmala Chandralega Kampan, et al.
Molecular Cancer Therapeutics|December 12, 2018
Combined PPARγ Activation and XIAP Inhibition as a Potential Therapeutic Strategy for Ovarian Granulosa Cell TumorsDilys T H Leung, Trang Nguyen, Edwina May Oliver, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
The Journal of the British Menopause Society|April 9, 2005
Advances in the treatment of endometrial cancerMartin K Oehler, Alison Fung, Thomas W Jobling
Journal of Gynecologic Oncology|September 26, 2015
Surgical staging of para-aortic LN in patients with locally advanced cervix cancer and no evidence of metastases in preoperative PET/CT imagingMing Yin Lin, Thomas W Jobling, Kailash Narayan
Cell and Tissue Research|June 11, 2005
Endometrial cancerAndrew J Ryan, Beatrice Susil, Thomas W Jobling, et al.
Cancers|August 25, 2019
Keratin-14 (KRT14) Positive Leader Cells Mediate Mesothelial Clearance and Invasion by Ovarian Cancer CellsMaree Bilandzic, Adam Rainczuk, Emma Green, et al.
Diagnostics (Basel, Switzerland)|July 2, 2021
Active Ratio Test (ART) as a Novel Diagnostic for Ovarian CancerSung-Woog Kang, Adam Rainczuk, Martin K Oehler, et al.
Diagnostics (Basel, Switzerland)|January 7, 2021
Diagnostic Value of Plasma Annexin A2 in Early-Stage High-Grade Serous Ovarian CancerNoor A Lokman, Carmela Ricciardelli, Andrew N Stephens, et al.
Acta Obstetricia Et Gynecologica Scandinavica|January 15, 2013
Surgical management of placenta accreta: a 10-year experienceS E Grace Tan, Thomas W Jobling, Euan M Wallace, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 2, 2021
Chemoresistance is mediated by ovarian cancer leader cells in vitroNazanin Karimnia, Amy L Wilson, Emma Green, et al.
Cancers|August 27, 2021
Mapping Epitopes Recognised by Autoantibodies Shows Potential for the Diagnosis of High-Grade Serous Ovarian Cancer and Monitoring Response to Therapy for This MalignancyRhiane Moody, Kirsty Wilson, Nirmala Chandralega Kampan, et al.
Molecular Cancer Therapeutics|December 12, 2018
Combined PPARγ Activation and XIAP Inhibition as a Potential Therapeutic Strategy for Ovarian Granulosa Cell TumorsDilys T H Leung, Trang Nguyen, Edwina May Oliver, et al.
Pageof 3